Pages that link to "Q33404972"
Jump to navigation
Jump to search
The following pages link to Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study). (Q33404972):
Displaying 48 items.
- Managing dyslipidemia in HIV/AIDS patients: challenges and solutions (Q28084941) (← links)
- Insulin resistance change and antiretroviral therapy exposure in HIV-infected and uninfected Rwandan women: a longitudinal analysis (Q30389026) (← links)
- Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study (Q33602915) (← links)
- Diabetes mellitus type 2 and abnormal glucose metabolism in the setting of human immunodeficiency virus (Q34157971) (← links)
- Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance (Q34367498) (← links)
- Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapy (Q34509012) (← links)
- Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment (Q34542179) (← links)
- Prevalence of hyperglycemia among adults with newly diagnosed HIV/AIDS in China (Q34581209) (← links)
- Cost-utility analysis of lopinavir/ritonavir versus atazanavir + ritonavir administered as first-line therapy for the treatment of HIV infection in Italy: from randomised trial to real world (Q34608823) (← links)
- Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials. (Q35030752) (← links)
- HIV and general cardiovascular risk (Q35118909) (← links)
- Obesity is associated with race/sex disparities in diabetes and hypertension prevalence, but not cardiovascular disease, among HIV-infected adults (Q36006866) (← links)
- Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management (Q36158019) (← links)
- HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2. (Q36221840) (← links)
- HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation (Q36327164) (← links)
- Nadir CD4+, religion, antiretroviral therapy, incidence of type 2 diabetes mellitus, and increasing rates of obesity among black Africans with HIV disease (Q36444419) (← links)
- Pathophysiology and management of cardiovascular disease in patients with HIV (Q37038775) (← links)
- Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s (Q37305570) (← links)
- Metabolic disorders and cardiovascular consequences of HIV infection and antiretroviral therapy (Q37960180) (← links)
- HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults (Q38021848) (← links)
- The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care (Q38023235) (← links)
- The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges (Q38024436) (← links)
- Diabetes and HIV: current understanding and future perspectives. (Q38085218) (← links)
- Evidence informing the intersection of HIV, aging and health: a scoping review (Q38159448) (← links)
- Cardiovascular disease in human immunodeficiency virus (Q38206287) (← links)
- Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now? (Q38596011) (← links)
- Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV (Q38821848) (← links)
- Insulin Resistance and Markers of Inflammation in HIV-infected Ugandan Children in the CHAPAS-3 Trial. (Q38851661) (← links)
- Cardiovascular Risk in HIV-Infected and Uninfected Postmenopausal Minority Women: Use of the Framingham Risk Score (Q38950123) (← links)
- Acute coronary syndromes in patients with HIV. (Q39009201) (← links)
- Greater carotid intima media thickness at a younger age in HIV-infected patients compared with reference values for an uninfected cohort (Q39540038) (← links)
- Comparative Effectiveness of Diabetic Oral Medications Among HIV-Infected and HIV-Uninfected Veterans (Q40538325) (← links)
- Cardiovascular disease risk scores' relationship to subclinical cardiovascular disease among HIV-infected and HIV-uninfected men. (Q40666123) (← links)
- Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study. (Q42609996) (← links)
- Arcelis AGS-004 dendritic cell-based immunotherapy for HIV infection (Q44606374) (← links)
- Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy (Q44881138) (← links)
- [Controversies and future of the approach to cardiovascular disease in HIV patients]. (Q52398755) (← links)
- HIV Infection, Antiretroviral Therapy and Cardiovascular Risk. (Q55210420) (← links)
- Atypical presentation of critical left main disease in an HIV-infected patient. (Q55404729) (← links)
- Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test - which method to choose for the diagnosis? (Q55510378) (← links)
- Approaches to improve the surveillance, monitoring, and management of noncommunicable diseases among HIV-infected persons (Preprint) (Q58816353) (← links)
- Risk of coronary heart disease among HIV-infected patients: a multicenter study in Brazil (Q59033147) (← links)
- The Impact of Weight Gain During HIV Treatment on Risk of Pre-diabetes, Diabetes Mellitus, Cardiovascular Disease, and Mortality (Q59806829) (← links)
- HIV disease, metabolic dysfunction and atherosclerosis: A three year prospective study (Q64103636) (← links)
- Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis (Q64137244) (← links)
- Social media use as a predictor of higher body mass index in persons living with HIV (Q89470623) (← links)
- Consensus statement on the assessment of comorbidities in people living with HIV in Romania (Q89640150) (← links)
- Cardiovascular, endothelial function, and immune markers in response to treatment with a polysaccharide in HIV+ adults in a randomized, double-blind placebo-controlled trial (Q97425625) (← links)